Rituximab Plus Lenalidomide or Rituximab Monotherapy for Untreated Patients With Follicular Lymphoma in Need of Therapy. A Randomized, Open-Label, Multicenter Phase II Trial.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 May 2018
At a glance
- Drugs Rituximab (Primary) ; Lenalidomide
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 06 Dec 2016 Results of first analysis of secondary endpoints presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
- 06 Dec 2016 Results (n=13) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
- 14 Apr 2016 Planned End Date changed from 1 Dec 2015 to 1 Mar 2023.